Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-20-129535
Filing Date
2020-11-25
Accepted
2020-11-25 16:31:10
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2037003d2_s3.htm S-3 237001
2 EXHIBIT 5.1 tm2037003d2_ex5-1.htm EX-5.1 14324
3 EXHIBIT 23.1 tm2037003d2_ex23-1.htm EX-23.1 4762
4 GRAPHIC tm2037003d2_s3img001.jpg GRAPHIC 10420
5 GRAPHIC image_001.jpg GRAPHIC 8149
6 GRAPHIC image_003.jpg GRAPHIC 29399
7 GRAPHIC image_004.jpg GRAPHIC 4486
8 GRAPHIC image_005.jpg GRAPHIC 22265
9 GRAPHIC image_006.jpg GRAPHIC 19366
  Complete submission text file 0001104659-20-129535.txt   387501
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: S-3 | Act: 33 | File No.: 333-250967 | Film No.: 201351050
SIC: 2834 Pharmaceutical Preparations